Cargando…

High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma

To clarify the relationship between aldo-keto reductase family 1 member B10 (AKR1B10) expression and early hepatocellular carcinoma (HCC) recurrence, this study detected AKR1B10 expression in tumor and adjacent non-tumor tissues from 110 patients with hepatitis B virus (HBV)-related HCC underwent li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan-Yan, Qi, Lu-Nan, Zhong, Jian-Hong, Qin, Hong-Gui, Ye, Jia-Zhou, Lu, Shi-Dong, Ma, Liang, Xiang, Bang-De, Li, Le-Qun, You, Xue-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299837/ https://www.ncbi.nlm.nih.gov/pubmed/28181486 http://dx.doi.org/10.1038/srep42199

Ejemplares similares

Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure
por: Xiang, Xiao, et al.
Publicado: (2017)

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
por: Ke, Yang, et al.
Publicado: (2013)

Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
por: DiStefano, Johanna K., et al.
Publicado: (2019)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015)

The Role of AKR1B10 in Physiology and Pathophysiology
por: Endo, Satoshi, et al.
Publicado: (2021)

Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma
por: Shi, Jia, et al.
Publicado: (2019)

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
por: Murata, Ayato, et al.
Publicado: (2016)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
por: Ejaz, Syeda Abida, et al.
Publicado: (2022)

Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and meta-analysis
por: Wang, Zixiang, et al.
Publicado: (2022)

AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy
por: Ahmed, Syed Minhaj Uddin, et al.
Publicado: (2019)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Meta-Analysis of Microsomal Epoxide Hydrolase Gene Polymorphism and Risk of Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2013)

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
por: Zhong, Jian-Hong, et al.
Publicado: (2016)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma
por: Lu, Shi-Dong, et al.
Publicado: (2016)

AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma
por: Geng, Nan, et al.
Publicado: (2020)

Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma
por: Han, Chao, et al.
Publicado: (2018)

Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma
por: Wu, Tiangen, et al.
Publicado: (2021)

Operable hepatitis B virus-related hepatocellular carcinoma: gut microbiota profile of patients at different ages
por: Peng, Yu-Chong, et al.
Publicado: (2022)

Genetic variants in AKR1B10 associate with human eating behavior
por: Rohde, Kerstin, et al.
Publicado: (2015)

Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma
por: Hung, Jung‐Jyh, et al.
Publicado: (2018)

The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma
por: Liu, Jixuan, et al.
Publicado: (2021)

Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway
por: Tian, Ke, et al.
Publicado: (2023)

AKR1B10 expression in benign prostatic hyperplasia and its related mechanism
por: Xu, Wenjing, et al.
Publicado: (2021)

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, China
por: Qi, Lu-Nan, et al.
Publicado: (2013)

Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma
por: Chung, Yeon Tae, et al.
Publicado: (2012)

Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL
por: Xie, Zhi-Bo, et al.
Publicado: (2016)

Prognostic value of aldo-keto reductase family 1 member B10 (AKR1B10) in digestive system cancers: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021)

CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling
por: Huang, Zhengnan, et al.
Publicado: (2021)

METTL3 promotes glycolysis and cholangiocarcinoma progression by mediating the m6A modification of AKR1B10
por: Cai, Jingli, et al.
Publicado: (2022)

Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion
por: Li, Hong-Hao, et al.
Publicado: (2018)

Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
por: Mo, Han-Yue, et al.
Publicado: (2016)

Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
por: Li-Shuai, Qu, et al.
Publicado: (2017)

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
por: Soares, Cleverson T., et al.
Publicado: (2018)

Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial‐mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4
por: Hao, Fengjie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kpplldne6glh2n2kad0mavi0h9